References
-
1) Lower Expression of Gelsolin in Colon Cancer and Its Diagnostic Value in Colon Cancer Patients.
Product: MMP9 Antibody (#AF5228)Year: 2019Journal: J CANCERImpactFactor: 3.3DOI: 10.7150/jca.28529PMID: 30854138 -
2) α7nAChR Prevents Premature Cervical Ripening by Inducing M2 Macrophage Polarization and Myofibroblast Differentiation.
-
3) RETRACTED ARTICLE: Hsp90β promotes aggressive vasculogenic mimicry via epithelial–mesenchymal transition in hepatocellular carcinoma.
Product: MMP9 Antibody (#AF5228)Year: 2018Journal: OncogeneImpactFactor: 6.9DOI: 10.1038/s41388-018-0428-4PMID: 30087438 -
4) CRTC2 promotes non-small cell lung cancer A549 migration and invasion in vitro.
Product: MMP9 Antibody (#AF5228)Year: 2018Journal: THORAC CANCERImpactFactor: 2.3DOI: 10.1111/1759-7714.12550PMID: 29105369 -
5) MicroRNA-139-5p affects cisplatin sensitivity in human nasopharyngeal carcinoma cells by regulating the epithelial-to-mesenchymal transition.
Product: MMP9 Antibody (#AF5228)Year: 2018Journal: GENEImpactFactor: 2.6DOI: 10.1016/j.gene.2018.02.003PMID: 29427737 -
6) Downregulation of castor zinc finger 1 predicts poor prognosis and facilitates hepatocellular carcinoma progression via MAPK/ERK signaling.
Product: MMP9 Antibody (#AF5228)Year: 2018Journal: J Exp Clin Cancer ResImpactFactor: 11.3DOI: 10.1186/s13046-018-0720-8PMID: 29506567 -
7) MFAP5 promotes tumor progression and bone metastasis by regulating ERK/MMP signaling pathways in breast cancer.
Product: MMP9 Antibody (#AF5228)Year: 2018Journal: BIOCHEM BIOPH RES COImpactFactor: 2.5DOI: 10.1016/j.bbrc.2018.03.007PMID: 29526753 -
8) BCL2L10 inhibits growth and metastasis of hepatocellular carcinoma both in vitro and in vivo.
Product: MMP9 Antibody (#AF5228)Year: 2017Journal: MOL CARCINOGENImpactFactor: 3DOI: 10.1002/mc.22580PMID: 27770580 -
9) Propofol protects against blood-spinal cord barrier disruption induced by ischemia/reperfusion injury.
Product: MMP9 Antibody (#AF5228)Year: 2017Journal: NEURAL REGEN RESImpactFactor: 5.9DOI: 10.4103/1673-5374.199004PMID: 28250758 -
10) Phenytoin silver: a new nanocompound for promoting dermal wound healing via comprehensive pharmacological action.
Product: MMP9 Antibody (#AF5228)Year: 2017Journal: THERANOSTICSImpactFactor: 12.4DOI: 10.7150/thno.17073PMID: 28255340 -
11) Dencichine ameliorates kidney injury in induced type II diabetic nephropathy via the TGF-β/Smad signalling pathway.
Product: MMP9 Antibody (#AF5228)Year: 2017Journal: EUR J PHARMACOLImpactFactor: 4.2DOI: 10.1016/j.ejphar.2017.06.024PMID: 28633927 -
12) Inflammation-mediated SOD-2 upregulation contributes to epithelial-mesenchymal transition and migration of tumor cells in aflatoxin G1-induced lung adenocarcinoma.
Product: MMP9 Antibody (#AF5228)Year: 2017Journal: SCI REP-UKImpactFactor: 3.8DOI: 10.1038/s41598-017-08537-2PMID: 28801561 -
13) HIF-1α/Malat1/miR-141 Axis Activates Autophagy to Increase Proliferation, Migration, and Invasion in Triple-negative Breast Cancer.
Product: MMP9 Antibody (#AF5228)Year: 2017Journal: Curr Cancer Drug TargetsImpactFactor: 2.3DOI: 10.2174/1568009623666221228104833PMID: 36579395 -
14) Fucoxanthin Activates Apoptosis via Inhibition of PI3K/Akt/mTOR Pathway and Suppresses Invasion and Migration by Restriction of p38-MMP-2/9 Pathway in Human Glioblastoma Cells.
Product: MMP9 Antibody (#AF5228)Year: 2016Journal: NEUROCHEM RESImpactFactor: 3.7DOI: 10.1007/s11064-016-1989-7PMID: 27394418 -
15) Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development.
Product: MMP9 Antibody (#AF5228)Year: 2016Journal: ONCOTARGETDOI: 10.18632/oncotarget.7071PMID: 26840018